Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria : data from the ARCTIC study
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 83(2024), 4 vom: 12. März, Seite 540-541 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Melokhina, Valeriia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antirheumatic Agents |
|---|
| Anmerkungen: |
Date Completed 14.03.2024 Date Revised 14.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/ard-2023-224950 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365409464 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365409464 | ||
| 003 | DE-627 | ||
| 005 | 20240314234716.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/ard-2023-224950 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1328.xml |
| 035 | |a (DE-627)NLM365409464 | ||
| 035 | |a (NLM)38049997 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Melokhina, Valeriia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria |b data from the ARCTIC study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2024 | ||
| 500 | |a Date Revised 14.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Arthritis | |
| 650 | 4 | |a Magnetic Resonance Imaging | |
| 650 | 4 | |a Rheumatoid | |
| 650 | 4 | |a Ultrasonography | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 700 | 1 | |a Paulshus Sundlisæter, Nina |e verfasserin |4 aut | |
| 700 | 1 | |a Sexton, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Sundin, Ulf |e verfasserin |4 aut | |
| 700 | 1 | |a Aga, Anna-Birgitte |e verfasserin |4 aut | |
| 700 | 1 | |a Kjørholt, Kaja E |e verfasserin |4 aut | |
| 700 | 1 | |a Nordberg, Lena Bugge |e verfasserin |4 aut | |
| 700 | 1 | |a van der Heijde, Désirée |e verfasserin |4 aut | |
| 700 | 1 | |a Haavardsholm, Espen |e verfasserin |4 aut | |
| 700 | 1 | |a Lillegraven, Siri |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 83(2024), 4 vom: 12. März, Seite 540-541 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2024 |g number:4 |g day:12 |g month:03 |g pages:540-541 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/ard-2023-224950 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2024 |e 4 |b 12 |c 03 |h 540-541 | ||